[1]
“Neutrophils phagocytic function in chronic myelogenous leukemia after imatinib mesylate therapy”, Iraqi j. cancer med. genet., vol. 6, no. 1, Jun. 2013, doi: 10.29409/ijcmg.v6i1.103.